ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 718370 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 718370; 2) Community: the network communities that were significantly associated with the response to NSC 718370; 3) Molecule: the relationships between components within communities and NSC 718370; 4) MDR: the compounds that were significantly associated with the NSC 718370.

NSC Compound Enrichment Correlation
NSC 693573 Null 0.0285477013888569 0.49444139
NSC 100880 Camptothecin 0.0297837393005856 -0.071641284
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0297837393005856 -0.17862098
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0297837393005856 0.19432069
NSC 135880 Null 0.0297837393005856 -0.0017540039
NSC 254665 JUSTICIDIN B 0.0297837393005856 -0.15026547
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0297837393005856 0.054081717
NSC 303861 L-Cysteine analog 0.0297837393005856 -0.13876483
NSC 313681 Oxiperomide(USAN) 0.0297837393005856 0.14559372
NSC 328410 Camptothecin Derivative 0.0297837393005856 -0.036848924
Total:86  Current:55    [First] [Prev] [Next] [Last]